Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.08
+0.25 (2.83%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $697.75 million as of April 24, 2025. Its market cap has increased by 59.64% in one year.
Market Cap
697.75M
Enterprise Value
237.26M
1-Year Change
59.64%
Ranking
Category
Stock Price
$9.08
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $697.75M, an increase of 49.25%. That is a compound annual growth rate of 6.10%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.25B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |